Namibia Internet Gateway


	Hello unlogged user	LINK1 · LINK2 · LINK3 · LINK4 · LINK5

gTLD

.com
.net
.org
.biz
.info
.us
.in
.cn
.eu
.cc
.ws
.mobi

.ki
.biz.ki
.org.ki
.com.ki
.phone.ki
.info.ki
.tel.ki
.mobi.ki
.net.ki

Mauritius

.mu

Namibia

.na
.com.na
.org.na
.net.na
.co.na
.alt.na
.edu.na
.in.na
.ws.na
.mobi.na
.tv.na

Norfolk Island

.nf

South Georgia & South Sandwich Islands

.gs

Timor-Leste

.tl

Namibian Towns

Languages

Preferred language:

Topic: Health

The new items published under this topic are as follows.

Effect of Torcetrapib on the progression of coronary atherosclerosis

Posted by: Admin on Monday, April 02, 2007 - 11:35 PM (138 Reads)

Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).

Read full article: 'Effect of Torcetrapib on the progression of coronary atherosclerosis' (628 words more)

ADHD is a risk factor for alcohol problems

Posted by: Admin on Monday, April 02, 2007 - 11:34 PM (140 Reads)

Researchers believe that children with attention deficit hyperactivity disorder (ADHD) are at risk for alcohol- as well as other substance-related problems as they grow older.

Read full article: 'ADHD is a risk factor for alcohol problems' (768 words more)

Postmenopausal women encouraged to maintain regular health care

Posted by: Admin on Monday, April 02, 2007 - 11:31 PM (123 Reads)

In North America, ovarian cancer is the second most common gynecological cancer and is the leading cause of death among women with gynecological cancer.

Read full article: 'Postmenopausal women encouraged to maintain regular health care' (174 words more)

Massachusetts health insurance connector board votes to require prescription drug coverage as part of draft minimum coverage requirements

Posted by: Admin on Monday, April 02, 2007 - 10:01 AM (134 Reads)

The Massachusetts Commonwealth Health Insurance Connector Authority on Tuesday approved minimum coverage requirements for health insurance plans to comply with the state's universal coverage law, including requiring prescription drug coverage, the New York Times reports.

Read full article: 'Massachusetts health insurance connector board votes to require prescription drug coverage as part of draft minimum coverage requirements' (499 words more)

Curecumin - potential treatment for lung cancer

Posted by: Admin on Monday, April 02, 2007 - 10:00 AM (143 Reads)

Bioponic Phytoceuticals has announced that its Curecumin (a Bioresonant Phytotherapeutic form of Turmeric containing curcumin in a liquid nasal delivery system) may be an important treatment for Lung Cancer.

Read full article: 'Curecumin - potential treatment for lung cancer' (282 words more)

Withdrawal of Pergolide products

Posted by: Admin on Monday, April 02, 2007 - 09:59 AM (125 Reads)

The U.S. Food and Drug Administration (FDA) today announced that manufacturers of pergolide drug products, which are used to treat Parkinson's disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients' heart valves.

Read full article: 'Withdrawal of Pergolide products' (615 words more)

FDA announces marketing halt for GI drug, Zelnorm

Posted by: Admin on Monday, April 02, 2007 - 09:58 AM (161 Reads)

The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.

Read full article: 'FDA announces marketing halt for GI drug, Zelnorm' (467 words more)

FDA approves Ceprotin to treat severe congenital protein C deficiency

Posted by: Admin on Monday, April 02, 2007 - 09:56 AM (109 Reads)

The U.S. Food and Drug Administration (FDA) today licensed Ceprotin, the first biologic treatment for patients with a rare genetic defect that can cause a potentially life-threatening clotting disorder.

Read full article: 'FDA approves Ceprotin to treat severe congenital protein C deficiency' (484 words more)

GlaxoSmithKline submits Biologics License Application (BLA) for CERVARIX

Posted by: Admin on Monday, April 02, 2007 - 09:55 AM (123 Reads)

GlaxoSmithKline has submitted a Biologics License Application (BLA) for CERVARIX (human papillomavirus vaccine, AS04 adjuvant-adsorbed), its cervical cancer candidate vaccine, to the U.S. Food and Drug Administration (FDA).

Read full article: 'GlaxoSmithKline submits Biologics License Application (BLA) for CERVARIX' (466 words more)

GlaxoSmithKline files European meningococcal conjugate vaccine

Posted by: Admin on Monday, April 02, 2007 - 09:54 AM (111 Reads)

GlaxoSmithKline has announced the submission of a regulatory file to European Medicines Agency (EMEA) under Article 58 for the combination vaccine candidate Globorix (diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, Neisseria meningitides serogroups A and C).

Read full article: 'GlaxoSmithKline files European meningococcal conjugate vaccine' (667 words more)

News Categories

Main Menu

Online

There are 3 unlogged users and 0 registered users online.

You can log-in or register for a user account here.

Ads